INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

Clinical trial NCT07224321 · RECRUITING

Trial details

NCT number: NCT07224321
Sponsor: Mannkind Corporation
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2026-02-04
Primary completion: 2027-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.